Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of b-Myb and miRNA34a expression = Ginkgetin의 항암 효과 및 기전 규명

Cited 20 time in scopus
Metadata Downloads
Title
Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of b-Myb and miRNA34a expression = Ginkgetin의 항암 효과 및 기전 규명
Author(s)
Yu Jin Lee; Yeong-Rim Kang; So Young Lee; Yena Jin; Dong Cho Han; Byoung-Mog Kwon
Bibliographic Citation
International Journal of Oncology, vol. 51, no. 5, pp. 1331-1342
Publication Year
2017
Abstract
Ginkgetin has been reported to display antitumor activity. However, the relevant pathway integrating cell cycle regulation and signaling pathways involved in growth inhibition in CRC cells remains to be identified. In this study, ginkgetin-treated HCT116 CRC cells exhibited significant dose-dependent growth inhibition with a GI50 value of 4.0 EM for 48-h treatment, together with apoptosis, via G2-phase cell cycle arrest. When HCT116 cells were treated with 10 ginkgetin for 48 h, the percentage of cells in G2/M phase increased by 2.2-fold (43.25%) versus the untreated control (19.69%). Ginkgetin regulated the expression of genes that are critically involved in G2 phase arrest cells, such as b.Myb, CDC2 and cyclin B1. Furthermore, we found that the suppression of b.Myb expression by ginkgetin was rescued ∼5.1-fold by treatment with a miR-34a inhibitor (500 nM) and b.Myb was downregulated by >80% by 100 nM miR.34a mimic. These data suggest that the miRNA34a/b.Myb/cyclin B1 cascade plays a critical role in ginkgetin-induced G2 cell cycle arrest, as well as in the inhibition of HCT116 cell proliferation. Moreover, the administration of ginkgetin (10 mg/kg) reduced tumor volumes by 36.5% and tumor weight by 37.6% in the mice xenografted with HCT116 cells relative to their vehicle-treated counterparts. Therefore, ginkgetin is the first compound shown to regulate b.Myb by modulating miR-34a, and we suggest the use of ginkgetin as an inducer of G2 arrest for the treatment of CRC.
ISSN
1019-6439
Publisher
Spandidos Publ Ltd
DOI
http://dx.doi.org/10.3892/ijo.2017.4116
Type
Article
Appears in Collections:
Division of Biomedical Research > Personalized Genomic Medicine Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.